Have you struggled to develop your search strategies for the state of the art evaluation? Are you finding yourself sorting through large amounts of data? This article outlines best practices for creating the state of the Art Evaluation under EU regulations. Access the article here.
Related Articles
The article is free!
Simply fill in the form below, verify your email address
and you’ll be sent a link to download the article.
Please wait...
Related Posts
- State of the Art for Medical Devices – Applying the Requirements of MEDDEV 2.7/1 Rev. 439By Nerac Regulatory Analysts Originally Published: July 31, 2018 The European Clinical Evaluation Guidance MEDDEV 2.7/1 Revision 4 updated many requirements for clinical evaluation of medical devices and provided detailed descriptions of what the Clinical Evaluation Report (CER) should encompass to assess and document safety and performance of a device. In particular, revision 4 clarifies…
- Without Clinical Data, European Compliance Can Appear Unattainable38By Robert Zott, Director of Advisory Services Development Originally published March 27, 2018 It’s easy to read Europe’s Clinical Evaluation Guidance Document MEDDEV 2.7/1 Revision 4 (referred to as “Rev. 4”) and come away with the impression that clinical data—whether in the form of investigations carried out by the manufacturer of a medical device or…
- The European In Vitro Diagnostic Regulation: Performance Evaluation31By Erica Kramer, Ph.D., Senior Nerac Analyst/Medical Writer Originally Published: June 30, 2020 In May 2017, the European Parliament and Council published Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR), repealing Directive 98/79/EC (IVDD). The new regulation will apply starting May 26, 2022. Unlike under the IVDD, which allowed for self-certification for many…
The post Best Practices for the State of the Art Evaluation appeared first on Nerac.
This post first appeared on Nerac Insights And Publications - Nerac, please read the originial post: here
